Dartmouth Hitchcock Medical Center clinicians are urging patients and primary care providers to treat the phrase “hormonal imbalance” as a non-specific description rather than a diagnostic label for symptoms that commonly occur during the transition to menopause.
“Hormonal imbalance” is a term that doesn’t hold much clinical meaning when talking about perimenopause and menopause
The guidance comes from Alexandra H. Woolley, CNM, WHNP-BC, MSCP, and Elizabeth L. Howland, DNP, FNP-BC, APRN, MSCP, of the Menopause and Midlife Clinic at Dartmouth Hitchcock. They say the changes people notice — including hot flashes, night sweats, sleep disruption, mood shifts and vaginal dryness — are consistent with the hormonal variability that defines perimenopause, the years leading up to menopause.
When testing helps and when it does not
Woolley and Howland note that, except in uncommon situations, broad hormone-panel lab testing does not provide useful information for managing menopause symptoms. Because hormone levels fluctuate markedly during the transition, the clinicians said, single blood draws rarely reflect a person’s overall hormonal pattern.
- Symptoms guide care: Treatment decisions should be based on which symptoms are bothersome and how well therapies relieve them.
- Testing limitations: Capturing meaningful hormone trends would require repeated sampling — impractical and usually unnecessary.
- Common symptoms: Hot flashes, night sweats, sleep problems, cognitive complaints, mood changes and painful sex are among the most frequently reported concerns.
The clinicians emphasized individualized care. For people whose symptoms clearly point to perimenopause, clinicians typically recommend management strategies targeted to specific complaints rather than broad endocrine testing. The Menopause and Midlife Clinic at Dartmouth Hitchcock provides specialized evaluation and treatment for people whose symptoms are severe or complex.
The Dartmouth Health guidance cautions against over-reliance on commercial or social media messaging that promotes broad hormone panels as a routine step for menopause care. The clinicians said that testing can be appropriate in select cases where other conditions are suspected or when treatment decisions depend on specific laboratory information, but those situations are the exception rather than the rule.
Patients with persistent or severe symptoms are encouraged to consult a clinician experienced in menopause care to discuss treatment options and whether any laboratory evaluation is warranted.
